Article info
PDFOriginal research
Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer
- Correspondence to Dr Yong Bae Kim, Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Korea (the Republic of); ybkim3{at}yuhs.ac
Citation
Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer
Publication history
- Received September 2, 2020
- Revision received November 16, 2020
- Accepted November 18, 2020
- First published December 3, 2020.
Article Versions
- You are currently viewing a Previous version of this article (4 January 2021).
- Previous version (4 January 2021).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.